Abivax Completes Recruitment of ABX464 Phase IIa HIV Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. SPY
2. TSLA
3. META
4. HOOD
5. STZ
6. INTC
7. AMZN
8. MSFT
9. SPCX
10. GOOGL

Go back to Abivax Completes Recruitment of ABX464 Phase IIa HIV Study
(NASDAQ: ABVX) Delayed: 144.65 +12.09 (9.12%)
Previous Close $132.56    52 Week High $ 
Open $138.87    52 Week Low $ 
Day High $146.68    P/E N/A 
Day Low $137.63    EPS $ 
Volume 4,020,747